메뉴 건너뛰기




Volumn 63, Issue 3, 2003, Pages 1051-1057

High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease

Author keywords

AL amyloidosis; Autologous stem cell transplantation; End stage renal disease; Melphalan; Renal failure; Treatment

Indexed keywords

MELPHALAN;

EID: 0037337542     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00813.x     Document Type: Article
Times cited : (58)

References (18)
  • 1
    • 0020555732 scopus 로고
    • Amyloidosis (AL). Clinical and laboratory features in 229 cases
    • KYLE RA, GREIPP PR: Amyloidosis (AL) Clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665-683, 1983
    • (1983) Mayo Clin Proc , vol.58 , pp. 665-683
    • Kyle, R.A.1    Greipp, P.R.2
  • 2
    • 0028970456 scopus 로고
    • Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
    • KYLE RA, GERTZ MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995
    • (1995) Semin Hematol , vol.32 , pp. 45-59
    • Kyle, R.A.1    Gertz, M.A.2
  • 3
    • 0030895545 scopus 로고    scopus 로고
    • A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine
    • KYLE RA, GERTZ MA, GREIPP PR, et al: A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336:1202-1207, 1997
    • (1997) N Engl J Med , vol.336 , pp. 1202-1207
    • Kyle, R.A.1    Gertz, M.A.2    Greipp, P.R.3
  • 4
    • 0026474596 scopus 로고
    • Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients
    • GERTZ MA, KYLE RA, O'FALLON WM: Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152:2245-2250, 1992
    • (1992) Arch Intern Med , vol.152 , pp. 2245-2250
    • Gertz, M.A.1    Kyle, R.A.2    O'Fallon, W.M.3
  • 5
    • 0029939944 scopus 로고    scopus 로고
    • Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only
    • SKINNER M, ANDERSON J, SIMMS R, et al: Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100:290-298, 1996
    • (1996) Am J Med , vol.100 , pp. 290-298
    • Skinner, M.1    Anderson, J.2    Simms, R.3
  • 6
    • 0033630225 scopus 로고    scopus 로고
    • The systemic amyloidoses: An overview
    • FALK RH, SKINNER M: The systemic amyloidoses: An overview. Adv Intern Med 45:107-137, 2000
    • (2000) Adv Intern Med , vol.45 , pp. 107-137
    • Falk, R.H.1    Skinner, M.2
  • 8
    • 0032525180 scopus 로고    scopus 로고
    • Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: Survival and responses in 25 patients
    • COMENZO RL, VOSBURGH E, FALK RH, et al: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: Survival and responses in 25 patients. Blood 91:3662-3670, 1998
    • (1998) Blood , vol.91 , pp. 3662-3670
    • Comenzo, R.L.1    Vosburgh, E.2    Falk, R.H.3
  • 9
    • 0032986336 scopus 로고    scopus 로고
    • Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis
    • COMENZO RL, SANCHORAWALA V, FISHER C, et al: Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol 104:553-559, 1999
    • (1999) Br J Haematol , vol.104 , pp. 553-559
    • Comenzo, R.L.1    Sanchorawala, V.2    Fisher, C.3
  • 10
    • 0034747773 scopus 로고    scopus 로고
    • An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    • SANCHORAWALA V, WRIGHT DG, SELDIN DC, et al: An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant 28:637-642, 2001
    • (2001) Bone Marrow Transplant , vol.28 , pp. 637-642
    • Sanchorawala, V.1    Wright, D.G.2    Seldin, D.C.3
  • 11
    • 0035340870 scopus 로고    scopus 로고
    • Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease
    • DEMBER LM, SANCHORAWALA V, SELDIN DC, et al: Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease. Ann Intern Med 134:746-753, 2001
    • (2001) Ann Intern Med , vol.134 , pp. 746-753
    • Dember, L.M.1    Sanchorawala, V.2    Seldin, D.C.3
  • 12
    • 0026034817 scopus 로고
    • Response rates and survival in primary systemic amyloidosis
    • GERTZ MA, KYLE RA, GREIPP PR: Response rates and survival in primary systemic amyloidosis. Blood 77:257-262, 1991
    • (1991) Blood , vol.77 , pp. 257-262
    • Gertz, M.A.1    Kyle, R.A.2    Greipp, P.R.3
  • 13
    • 0034012359 scopus 로고    scopus 로고
    • Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report
    • GERTZ MA, LACY MQ, DISPENZIERI A: Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report. Bone Marrow Transplant 25:465-470, 2000
    • (2000) Bone Marrow Transplant , vol.25 , pp. 465-470
    • Gertz, M.A.1    Lacy, M.Q.2    Dispenzieri, A.3
  • 15
    • 0000594647 scopus 로고    scopus 로고
    • High-dose melphalan and stem cell rescue for AL amyloidosis
    • edited by Kyle R, Gertz M, Pearl River, New York, Parthenon Publishing
    • GILLMORE J, APPERLEY J, CRADDOCK C: High-dose melphalan and stem cell rescue for AL amyloidosis, in Amyloid and Amyloidosis 1998, edited by KYLE R, GERTZ M, Pearl River, New York, Parthenon Publishing, 1999, pp 102-104
    • (1999) Amyloid and Amyloidosis 1998 , pp. 102-104
    • Gillmore, J.1    Apperley, J.2    Craddock, C.3
  • 16
    • 7144251173 scopus 로고    scopus 로고
    • Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients
    • MOREAU P, LEBLOND V, BOURQUELOT P, et al: Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients. Br J Haematol 101:766-769, 1998
    • (1998) Br J Haematol , vol.101 , pp. 766-769
    • Moreau, P.1    Leblond, V.2    Bourquelot, P.3
  • 17
    • 0034799598 scopus 로고    scopus 로고
    • Results of autologous stem cell transplant in multiple myeloma patients with renal failure
    • BADROS A, BARLOGIE B, SIEGEL E, et al: Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 114:822-829, 2001
    • (2001) Br J Haematol , vol.114 , pp. 822-829
    • Badros, A.1    Barlogie, B.2    Siegel, E.3
  • 18
    • 0033920690 scopus 로고    scopus 로고
    • Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
    • TOSI P, ZAMAGNI E, RONCONI S, et al: Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. Leukemia 14:1310-1313, 2000
    • (2000) Leukemia , vol.14 , pp. 1310-1313
    • Tosi, P.1    Zamagni, E.2    Ronconi, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.